Kari Remes

4.3k total citations
99 papers, 2.4k citations indexed

About

Kari Remes is a scholar working on Hematology, Oncology and Genetics. According to data from OpenAlex, Kari Remes has authored 99 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 61 papers in Hematology, 37 papers in Oncology and 30 papers in Genetics. Recurrent topics in Kari Remes's work include Multiple Myeloma Research and Treatments (32 papers), Chronic Lymphocytic Leukemia Research (23 papers) and Acute Myeloid Leukemia Research (17 papers). Kari Remes is often cited by papers focused on Multiple Myeloma Research and Treatments (32 papers), Chronic Lymphocytic Leukemia Research (23 papers) and Acute Myeloid Leukemia Research (17 papers). Kari Remes collaborates with scholars based in Finland, Sweden and Norway. Kari Remes's co-authors include Maija Itälä, Herman Adlercreutz, Kimmo Kuoppasalmi, Eeva Juvonen, Liisa Volin, Tarja‐Terttu Pelliniemi, Matti Härkönen, Tapani Ruutu, Mats Remberger and Olle Ringdén and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Kari Remes

96 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kari Remes Finland 29 1.1k 652 574 479 453 99 2.4k
G Pasero Italy 29 777 0.7× 509 0.8× 346 0.6× 374 0.8× 780 1.7× 117 4.9k
Paola Di Benedetto Italy 32 584 0.5× 280 0.4× 321 0.6× 849 1.8× 540 1.2× 70 2.7k
Kíyoyuki Ogata Japan 23 1.5k 1.3× 510 0.8× 582 1.0× 388 0.8× 231 0.5× 84 2.3k
Nemanja Damjanov Serbia 23 433 0.4× 278 0.4× 384 0.7× 440 0.9× 544 1.2× 95 2.3k
Е. Л. Насонов Russia 25 782 0.7× 270 0.4× 334 0.6× 464 1.0× 328 0.7× 399 3.2k
Onorina Berardicurti Italy 31 827 0.8× 204 0.3× 254 0.4× 689 1.4× 410 0.9× 88 2.6k
Matija Tomšič Slovenia 28 606 0.6× 441 0.7× 192 0.3× 318 0.7× 270 0.6× 131 2.8k
Satoshi Yamasaki Japan 32 564 0.5× 196 0.3× 582 1.0× 606 1.3× 332 0.7× 188 3.1k
Joseph A. Markenson United States 20 1.0k 0.9× 414 0.6× 170 0.3× 192 0.4× 278 0.6× 42 3.0k
Ignazio Majolino Italy 27 1.5k 1.3× 467 0.7× 696 1.2× 390 0.8× 336 0.7× 103 2.3k

Countries citing papers authored by Kari Remes

Since Specialization
Citations

This map shows the geographic impact of Kari Remes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kari Remes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kari Remes more than expected).

Fields of papers citing papers by Kari Remes

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kari Remes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kari Remes. The network helps show where Kari Remes may publish in the future.

Co-authorship network of co-authors of Kari Remes

This figure shows the co-authorship network connecting the top 25 collaborators of Kari Remes. A scholar is included among the top collaborators of Kari Remes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kari Remes. Kari Remes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Itälä‐Remes, Maija, Tommi Kauko, Urpu Salmenniemi, et al.. (2018). Treatment of adult acute myeloid leukemia.. PubMed. 132(16). 1465–73. 1 indexed citations
2.
Kontro, Mika, Ashwini Kumar, Muntasir Mamun Majumder, et al.. (2016). HOX gene expression predicts response to BCL-2 inhibition in acute myeloid leukemia. Leukemia. 31(2). 301–309. 66 indexed citations
3.
Silvennoinen, Raija, Tuija Lundán, Veli Kairisto, et al.. (2014). Comparative analysis of minimal residual disease detection by multiparameter flow cytometry and enhanced ASO RQ-PCR in multiple myeloma. Blood Cancer Journal. 4(10). e250–e250. 26 indexed citations
4.
Itälä‐Remes, Maija, Tommi Kauko, Marjut Kauppila, et al.. (2014). [Adult acute lymphoblastic leukemia - 20-year treatment results at TYKS].. PubMed. 130(7). 714–20. 1 indexed citations
5.
Merup, Mats, Gunnar Birgegård, Lorentz Brinch, et al.. (2011). The outcome of allo-HSCT for 92 patients with myelofibrosis in the Nordic countries. Bone Marrow Transplantation. 47(3). 380–386. 43 indexed citations
6.
Syrjälä, Hannu, Pasi Ohtonen, Riikka Räty, et al.. (2010). Blood stream infections during chemotherapy-induced neutropenia in adult patients with acute myeloid leukemia: treatment cycle matters. European Journal of Clinical Microbiology & Infectious Diseases. 29(10). 1211–1218. 28 indexed citations
7.
Jantunen, Esa, Maija Itälä, Timo Siitonen, et al.. (2007). Blood stem cell mobilization and collection in patients with chronic lymphocytic leukaemia: a nationwide analysis. Bone Marrow Transplantation. 41(3). 239–244. 16 indexed citations
8.
9.
Remes, Kari, et al.. (2003). Autologous Blood Cell Transplantation in Multiple Myeloma: Impact of CD34 + Cell Selection with Long Follow-Up. Journal of Hematotherapy & Stem Cell Research. 12(1). 63–70. 2 indexed citations
10.
Jantunen, Esa, Tom Wiklund, Eeva Juvonen, et al.. (2003). Autologous stem cell transplantation in adult patients with peripheral T-cell lymphoma: a nation-wide survey. Bone Marrow Transplantation. 33(4). 405–410. 56 indexed citations
11.
12.
Remes, Kari, et al.. (2000). Telomere length and telomerase activity in malignant lymphomas at diagnosis and relapse. British Journal of Cancer. 82(3). 601–607. 37 indexed citations
13.
Pelliniemi, T‐T., et al.. (2000). Serum oncostatin M in multiple myeloma: impact on disease severity and prognosis. European Journal Of Haematology. 65(1). 52–56. 8 indexed citations
14.
Kauppila, Marjut, Pertti Koskinen, Kerttu Irjala, Kari Remes, & Jorma Viikari. (1998). Long-term effects of allogeneic bone marrow transplantation (BMT) on pituitary, gonad, thyroid and adrenal function in adults. Bone Marrow Transplantation. 22(4). 331–337. 48 indexed citations
15.
Remes, Kari, Irma Matinlauri, Seija Grénman, et al.. (1997). Daily Measurements of Blood CD34+ Cells After Stem Cell Mobilization Predict Stem Cell Yield and Posttransplant Hematopoietic Recovery. Journal of Hematotherapy. 6(1). 13–19. 35 indexed citations
16.
Itälä, Maija, T‐T. Pelliniemi, Allan Rajamäki, & Kari Remes. (1997). Autologous blood cell transplantation in B-CLL: response to chemotherapy prior to mobilization predicts the stem cell yield. Bone Marrow Transplantation. 19(7). 647–651. 29 indexed citations
17.
Itälä, Maija, Tarja‐Terttu Pelliniemi, & Kari Remes. (1996). GM‐CSF RAISES SERUM LEVELS OF β2‐MICROGLOBULIN AND THYMIDINE KINASE IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKAEMIA. British Journal of Haematology. 94(1). 129–132. 6 indexed citations
18.
Itälä, Maija & Kari Remes. (1996). The COP Regimen is not a Feasible Treatment for Advanced, Refractory Chronic Lymphocytic Leukemia. Leukemia & lymphoma. 23(1-2). 137–141. 8 indexed citations
19.
Björkstrand, B., A. H. Goldstone, Per Ljungman, et al.. (1994). Prognostic Factors in Autologous Stem Cell Transplantation for Multiple Myeloma: An EBMT Registry Study. Leukemia & lymphoma. 15(3-4). 265–272. 43 indexed citations
20.
Remes, Kari, Anri Tienhaara, & T‐T. Pelliniemi. (1993). Alpha interferon raises serum beta‐2‐microglobulin in patients treated for thrombocythaemia. British Journal of Haematology. 84(2). 353–355. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by G Pasero Breakdown of academic impact, for papers by Paola Di Benedetto Breakdown of academic impact, for papers by Kíyoyuki Ogata Breakdown of academic impact, for papers by Nemanja Damjanov Breakdown of academic impact, for papers by Е. Л. Насонов Breakdown of academic impact, for papers by Onorina Berardicurti Breakdown of academic impact, for papers by Matija Tomšič Breakdown of academic impact, for papers by Satoshi Yamasaki Breakdown of academic impact, for papers by Joseph A. Markenson Breakdown of academic impact, for papers by Ignazio Majolino
Rankless by CCL
2026